Argá Medtech

Argá Medtech

Private
Epalinges, VaudHealthcare & Life Scienceshttps://www.argamedtech.com

Last Round

Series B

Feb 27, 2024

Total Funding Raised

$58.62M

Company Overview

Argá Medtech is a medical technology company that develops a proprietary coherent sine-burst electroporation system for treating cardiac arrhythmias, enhancing power and depth for effective ventricular tachycardia treatment while improving clinical efficiency and patient outcomes.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

pulsed field ablationPFAcardiac ablationatrial fibrillationAFibelectroporationablation catheterelectrophysiologyEP labsine-wave PFAnon-thermal ablationcardiac arrhythmiasmedical deviceMedTechablation generatorCoherent Sine-Burst ElectroporationCSE

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Argá Medtech Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Argá Medtech Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BFeb 27, 2024

Key People

Founding team and executive leadership

Randy Werneth

Chief Technology Officer

Executive Team

Argá Medtech Investors

Notable investors and investment history

InvestorRounds
Advent Life SciencesSeries B, Series A
Gilde HealthcareSeries B
Earlybird HealthSeries A, Series B
Earlybird Venture CapitalSeries B
High-Tech GründerfondsSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 18, 2025

    Developing a Coherent Sine-Burst Electroporation system for cardiac arrhythmias.

Argá Medtech Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Argá Medtech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Argá Medtech's valuation, stock price, and market status.

Firmographic Details

HeadquartersEpalinges, Vaud
Employee Range34
Year Founded2020
Last FundingFeb 27, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.